Worn on the upper arm, Nerivio® stimulates small nerves that send messages to a brainstem pain regulation center that can inhibit pain signals by releasing neurotransmitters, resulting in significant pain relief and an end to a migraine attack.

This wearable device, approved by the Food & Drug Administration, relies on a novel technique developed by its manufacturer, Theranica, to deploy remote electrical neuromodulation (REN) to counter migraines.

People who experience chronic migraines, which is 15 or more days a month, tend to have more severe attacks than those patients who get migraines less often. Nerivio® is used to fight chronic migraines instead of having patients taking more medication, which can cause medication-overuse headache and other complications.

Non-pharmacological interventions like REN meet this need in a drug-free treatment option.

Learn More: 

Headache Center